Early breast cancer

Giredestrant Beats Standard Endocrine Therapies Irrespective of Menopausal Status in Patients with ER+, HER2- Early Breast Cancer An interview with: Peter Schmid MD PhD, Professor of Cancer Medicine;

Although breast conserving therapy has proved of equivalent efficacy to mastectomy in many patients with early breast cancer, mastectomy was associated with longer survival among those with HER2 posit